Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prophylactic Filgrastim SD/01 in Hodgkin's Disease Receiving ABVD
NCT00038558Phase 3Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Nov 2001
- Primary completion
- Feb 2004
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of pegfilgrastim in chemotherapy-induced neutropenia (CIN), sponsored by University of Texas MD Anderson Cancer Center. Started Nov 2001; status: completed.
02
Drugs
pegfilgrastim
03
Conditions
chemotherapy-induced neutropenia (CIN)
Beyond the preview
Go deeper on NCT00038558.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00038558.